Cellectar biosciences reports financial results for q3 2024 and provides a corporate update

Phase 2 clover-wam pivotal study data selected for oral presentation at 66 th annual american society of hematology meeting and exposition

CLRB Ratings Summary

CLRB Quant Ranking